13 Followers on Owler
Juventas is a biotechnology company that discovers and develops non-viral gene therapies for the treatment of chronic cardiovascular diseases...
Read moreJuventas is a biotechnology company that discovers and develops non-viral gene therapies for the treatment of chronic cardiovascular diseases...
Read more
News
Sep 16, 2019
ChinaBio Today
Juventas: CASI Files for China Trials of CD19 CAR-T Candidate
Jun 17, 2019
Contract Pharma
Juventas: CASI Acquires Anti-CD19 T-cell Therapy from Juventas
Dec 03, 2018
StreetInsider
Press Release: Juventas : Merchavia's Portfolio Company 'Juventas' Announces Strategic Commercialization Agreement
Nov 22, 2018
FirstWord Pharma
Juventas: Astellas Executes License Agreement with an Option to Acquire JVS-100 Gene Therapy Program from Juventas
Aug 18, 2018
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Nov 02, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250
Oct 02, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
May 10, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 26042017 Prices from USD $250
Apr 19, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 20032017 Prices from USD $250
Jan 18, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Juventas Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to Juventas?
Juventas News
Juventas Press Releases
Juventas Headquarters
Juventas Summary
ABOUT
Overview
Juventas is a biotechnology company that discovers and develops non-viral gene therapies for the treatment of chronic cardiovascular diseases. Juventas was founded in 2007. Juventas' headquarters is located in Cleveland, Ohio, USA 44114. Juventas' Pr...CEO
Juventas's President & CEO, Rahul Aras, currently has an approval rating of 72%. Juventas's primary competitors are Medicure, Athersys & Renova Therapeutics.Website
juventasinc.comCompetitors
View 19 Juventas competitors here.Acquisitions
There have been no acquisitions found related to JuventasInvestments
Recent investment data cannot be found related to JuventasFrequently Asked Questions about Juventas
When was Juventas founded?
Juventas was founded in 2007Who is Juventas's CEO?
Juventas's CEO is Rahul ArasHow much revenue does Juventas generate?
Juventas generates $ < 1M in revenueHow much funding does Juventas have?
Juventas has historically raised $76M in funding
Where is Juventas's headquarters?
Juventas's headquarters is in Cleveland Ohio, USAHow many employees does Juventas have?
Juventas has 54 employeesWhat sector does Juventas operate in?
Juventas is in BiotechnologyWho are Juventas's competitors?
Juventas's top competitors are Medicure, Athersys, Renova Therapeutics